Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Bronchial artery embolization (BAE) is an effective treatment for hemoptysis, with potential complications including pain and spinal ischemia. We report a rare case in which the right bronchial artery communicated with the right intercostal arteries, and the right intercostal artery had an anastomosis with the right vertebral artery. Additionally, the left bronchial artery was found to have a connection with the left vertebral artery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12178182 | PMC |
| http://dx.doi.org/10.3389/fmed.2025.1585686 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
(R)-vanzacaftor potentiates BK channels in the absence of CFTR correction or potentiation.
Am J Physiol Cell Physiol
September 2025
Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA.
We previously demonstrated the CFTR correctors VX-445 (elexacaftor) and S-VX-121 (vanzacaftor) potentiate heterologously-expressed BK channels, as well as in primary human bronchial epithelial cells (HBEs). This potentiation of BK resulted in altered vasoreactivity and neuronal excitability. We postulated novel compounds could be identified that would potentiate BK while not affecting CFTR.
View Article and Find Full Text PDFSuccessful Treatment of Aspergilloma With Antifungal Alone: A Case of Conservative Management.
Respirol Case Rep
August 2025
Division of Respiratory Medicine, Department of Internal Medicine Melaka Hospital Melaka Malaysia.
Pulmonary aspergilloma can cause life-threatening haemoptysis. Surgical resection and/or bronchial artery embolization (BAE) are established treatment modalities, but both can be risky in frail patients with comorbidities. Spontaneous regression of aspergilloma with antifungal agents alone is rare.
View Article and Find Full Text PDFPulmonary aspergilloma is an uncommon but potentially life-threatening condition that predominantly affects individuals with pre-existing structural lung disease and immunosuppression. Systemic lupus erythematosus (SLE), especially with long-term immunosuppressive therapy, significantly increases susceptibility to opportunistic infections, including fungal pathogens such as species. These patients are also at heightened risk for a broad range of opportunistic infections, such as species, viral infections such as herpes zoster and cytomegalovirus (CMV), , and pneumonia (PJP).
View Article and Find Full Text PDFExclusion of Rasmussen Aneurysm: CT Technique.
J Belg Soc Radiol
August 2025
UZ Gent, Corneel Heymanslaan 10, 9000 Gent, Belgium.
Pulmonary and systemic arterial phases are needed to exclude Rasmussen aneurysm.
View Article and Find Full Text PDFShort-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy combined with bronchial artery embolization on massive hemoptysis.
Front Surg
August 2025
Department of Endoscopy, Henan Provincial Chest Hospital, Zhengzhou, Henan, China.
Background: To explore the short-term prognosis, mid- and long-term clinical follow-up of bronchoscopic intervention therapy (BIT) combined with bronchial artery embolization (BAE) in the treatment of massive hemoptysis.
Methods: Patients with massive hemoptysis who received BAE (BAE group) or BAE combined with BIT (BAE & BIT group) based on standard clinical treatment were included retrospectively, during June 2022 and March 2023. The short-term prognosis assessed by the therapeutic response, hemoptysis recurrence rates at 1-month post-surgery, and postoperative complications were compared.